의료용 가스 및 장비 시장 : 제품 유형별, 공급원별, 용도별, 최종 사용자별, 유통 채널별 시장 예측(2026-2032년)

The Medical Gas & Equipment Market is projected to grow by USD 31.56 billion at a CAGR of 8.24% by 2032.

The medical gas and equipment market is a mission-critical part of healthcare infrastructure, supporting anesthesia, intensive care, emergency medicine, respiratory therapy, neonatal care, diagnostics, laboratories, and home healthcare. Core medical gases include oxygen, medical air, nitrous oxide, carbon dioxide, nitrogen, helium, nitric oxide, and specialty gas mixtures, while the equipment ecosystem spans cylinders, bulk cryogenic tanks, manifolds, regulators, flowmeters, vacuum systems, compressors, pipeline networks, alarms, analyzers, and monitoring devices.

Demand is anchored in verified clinical need: oxygen is included on the World Health Organization Model List of Essential Medicines, and medical gases are regulated in major markets as healthcare products requiring quality control, traceability, labeling, pharmacopoeial conformity, and safe distribution. Market competitiveness increasingly depends on supply reliability, regulatory compliance, digital monitoring, infection-control readiness, and the ability to support both high-acuity hospitals and decentralized care settings.

Transformative Shifts in the Medical Gas Landscape

The landscape is shifting from cylinder-dependent supply toward integrated, telemetry-enabled gas delivery systems that combine bulk storage, pipeline infrastructure, automated manifolds, and point-of-care monitoring. Hospitals are prioritizing surge capacity after the documented oxygen constraints experienced globally during COVID-19, while safety standards such as NFPA 99 and ISO 7396-1 continue to shape system design, installation, maintenance, and risk management.

Another structural shift is the rise of home respiratory care and ambulatory treatment models, driven by aging populations and the documented burden of chronic respiratory diseases. At the same time, sustainability is becoming a procurement factor as healthcare systems examine nitrous oxide emissions, anesthetic gas waste, energy use in gas production, cylinder logistics, and opportunities for leak reduction, scavenging, and optimized distribution.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating measurable value across medical gas operations by improving forecasting, asset uptime, and distribution efficiency. AI-enabled analytics can use tank telemetry, flow history, refill cycles, alarm events, route data, and equipment performance records to anticipate demand, detect abnormal consumption, identify leaks, and reduce avoidable emergency deliveries. These capabilities are especially relevant for oxygen systems, where continuity of supply is directly linked to patient safety.

In clinical and facility environments, AI supports predictive maintenance for compressors, vacuum pumps, valves, vaporizers, alarms, and manifolds, helping providers move from reactive service to condition-based intervention. Adoption must remain governed by validated algorithms, cybersecurity controls, audit trails, human oversight, and medical device regulations, particularly when AI outputs influence alarms, oxygen titration, ventilator support, or other patient-facing decisions.

Key Regional Insights

Asia-Pacific is gaining strategic importance as China, India, Japan, South Korea, Australia, and ASEAN markets expand hospital capacity, strengthen domestic manufacturing, and invest in oxygen infrastructure, including bulk liquid oxygen systems, oxygen concentrators, and pressure swing adsorption plants. North America remains a highly regulated and technologically mature region, with the United States and Canada emphasizing FDA-regulated medical gases, USP-aligned quality expectations, NFPA-compliant systems, home oxygen services, and reliable distribution networks across urban, rural, and remote care settings.

Latin America shows rising modernization in Brazil, Mexico, and major metropolitan health systems, although infrastructure consistency, maintenance capability, and affordability remain key constraints. Europe benefits from harmonized quality expectations, strong hospital engineering standards, medicinal gas regulation, and increasing attention to low-emission anesthesia practices. The Middle East, led by high-investment GCC healthcare systems, is expanding tertiary care, specialty hospitals, and emergency preparedness capacity, while Africa continues to prioritize oxygen access through cylinders, concentrators, and pressure swing adsorption plants in line with global health oxygen initiatives and national health-system strengthening programs.

Key Group Insights

ASEAN demand is shaped by hospital expansion, medical tourism, and public health investment, with Indonesia, Vietnam, Thailand, Malaysia, and the Philippines strengthening critical care capacity and medical oxygen readiness. GCC countries are investing in advanced hospitals, specialty clinics, emergency preparedness, and internationally accredited healthcare facilities, creating demand for integrated pipeline systems, high-purity gases, validated storage, and premium equipment maintenance services. The European Union benefits from harmonized regulatory frameworks, CE-marked equipment pathways, Good Manufacturing Practice expectations for medicinal gases, and sustainability-led procurement.

BRICS markets represent large-scale demand potential due to population size, urban healthcare expansion, infectious and chronic respiratory disease burdens, and domestic manufacturing priorities in China, India, Brazil, Russia, and South Africa. G7 countries lead in mature medical gas infrastructure, aging-population care, advanced home respiratory services, stringent quality systems, and digital facility management. NATO members place additional emphasis on healthcare resilience, field medical readiness, interoperable logistics, and continuity of critical medical oxygen and equipment supplies during emergencies and cross-border disruptions.

Key Country Insights

The United States is defined by FDA oversight, USP standards, NFPA 99 compliance, extensive hospital networks, and a large home oxygen base, while Canada emphasizes universal healthcare delivery, remote access, provincial procurement models, and safe supply across geographically dispersed communities. Mexico is benefiting from healthcare modernization and manufacturing proximity to North America, and Brazil remains Latin America's largest healthcare system, supported by both public SUS demand and private hospital investment.

In Europe, the United Kingdom relies on NHS estate standards and HTM-aligned practices, Germany and France maintain strong medtech, hospital engineering, and quality-system capabilities, Russia is focused on domestic supply resilience, and Italy and Spain reflect aging-population demand for respiratory, surgical, and critical care. In Asia-Pacific, China and India combine large patient populations with expanding local production and oxygen infrastructure, Japan faces high elderly-care and home respiratory demand, Australia prioritizes reliable supply across remote geographies and hospital networks, and South Korea integrates advanced hospital technology with strong manufacturing capability.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize resilient supply architecture that combines bulk oxygen, backup cylinders, validated manifolds, tested alarm systems, leak management, and documented emergency operating procedures. Investment in preventive maintenance, installer certification, staff training, pharmacovigilance where applicable, and compliance audits is essential because medical gas failures can directly affect anesthesia, ventilation, intensive care, neonatal support, and emergency response.

Companies should also accelerate digital monitoring, AI-assisted demand planning, and remote asset management while maintaining strict validation, cybersecurity, and data governance. Growth strategies should align with home healthcare, oxygen access programs, sustainable anesthesia initiatives, localized manufacturing partnerships, and lifecycle service models. Suppliers that combine regulatory expertise, clinical safety, lifecycle services, and reliable logistics will be better positioned than companies competing on commodity gas pricing alone.

Research Methodology

This executive summary is built from verified secondary research and regulatory intelligence, including public information from the World Health Organization, U.S. Food and Drug Administration, European regulatory frameworks, national health authorities, ISO and NFPA standards, public hospital infrastructure guidance, pharmacopoeial references, peer-reviewed healthcare literature, and recognized healthcare utilization sources. The analysis emphasizes facts that can be validated through official and industry-recognized references.

The methodology applies triangulation across demand drivers, regulatory requirements, technology adoption, regional healthcare infrastructure, safety standards, and supply-chain considerations. Segmentation logic covers gases, equipment, delivery systems, applications, end users, and geographies. Insights were screened to avoid unsupported market-size claims and to focus on durable, evidence-based factors shaping medical gas and equipment purchasing decisions.

Conclusion

Medical gas and equipment is evolving from a utility category into a strategic healthcare infrastructure market. Oxygen access, compliant pipeline systems, reliable equipment, validated quality controls, and real-time monitoring are now central to clinical resilience, hospital accreditation, emergency readiness, and patient safety. The strongest opportunities are emerging where regulation, digitalization, sustainability, and infrastructure investment intersect.

Future market leadership will depend on trusted quality systems, responsive service models, supply continuity, and the ability to support care across hospitals, ambulatory centers, laboratories, and homes. Organizations that integrate compliance, AI-enabled operations, sustainability, and regional localization will be best positioned to capture long-term value in the global medical gas and equipment ecosystem.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Medical Gas & Equipment Market, by Product Type

• 7.1. Medical Gas
  • 7.1.1. Carbon Dioxide
  • 7.1.2. Helium
  • 7.1.3. Medical Air
  • 7.1.4. Nitrogen
  • 7.1.5. Nitrous Oxide
  • 7.1.6. Oxygen
• 7.2. Equipment Type
  • 7.2.1. Anesthesia Machines
  • 7.2.2. Gas Cylinders
  • 7.2.3. Gas Generators
  • 7.2.4. Incubators
  • 7.2.5. Regulator Systems
  • 7.2.6. Vacuum Pumps

8. Medical Gas & Equipment Market, by Source

• 8.1. Cylinder
• 8.2. Onsite Generation
  • 8.2.1. Membrane Separation
  • 8.2.2. Psa
• 8.3. Pipeline

9. Medical Gas & Equipment Market, by Application

• 9.1. Anesthesia
• 9.2. Dental Procedures
• 9.3. Imaging
• 9.4. Respiratory Therapy
• 9.5. Sterilization

10. Medical Gas & Equipment Market, by End User

• 10.1. Ambulatory Surgery Centers
• 10.2. Dental Clinics
• 10.3. Diagnostic Centers
• 10.4. Home Healthcare
• 10.5. Hospitals

11. Medical Gas & Equipment Market, by Distribution Channel

• 11.1. Direct Sales
• 11.2. Distributors

12. Medical Gas & Equipment Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. Medical Gas & Equipment Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Medical Gas & Equipment Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Concentration Analysis, 2025
  • 15.1.1. Concentration Ratio (CR)
  • 15.1.2. Herfindahl Hirschman Index (HHI)
• 15.2. Recent Developments & Impact Analysis, 2025
• 15.3. Product Portfolio Analysis, 2025
• 15.4. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Allied Healthcare Products, Inc.
• 16.2. Amcaremed Technology Co., Limited
• 16.3. Amico Group of Companies
• 16.4. ARAS Group of Companies
• 16.5. Atlas Copco Group
• 16.6. Avante Health Solutions
• 16.7. Digiline Systems Private Limited
• 16.8. Ellenbarrie industrial Gases
• 16.9. GCE Group AB
• 16.10. GE Healthcare
• 16.11. Genstar Technologies Co, Inc.
• 16.12. Greggersen Gasetechnik GmbH
• 16.13. Honeywell International Inc.
• 16.14. ILMO Products Company
• 16.15. Koninklijke Philips N.V.
• 16.16. Linde PLC
• 16.17. MagGas Medical Inc.
• 16.18. MEC Medical Ltd.
• 16.19. Nippon Sanso Holdings Corporation
• 16.20. Ohio Medical LLC
• 16.21. Pattons Medical
• 16.22. Powerex
• 16.23. Rotarex S.A.
• 16.24. Schonn Medizintechnik GmbH
• 16.25. Silbermann Medical Gas Systems
• 16.26. SOL Group
• 16.27. Yueyang kameter electronic special rare gas co., LTD.